Nine out of ten patients with prostate cancer treated with radiotherapy robotic Cyberknife maintain their sexual capacity.

Madrid, July of 2012. During the course of robotic Radioterapia Guiada por Imagen in time Real – CyberKnife which was held in the center of formation of the Foundation group IMO on 21 and 22 June in Madrid, Dr. Rafael Garcia, Coordinator of the radiotherapy and robotic radiosurgery center – group CyberKnife IMO has referred to , between 80 and 90% of patients with early stage prostate cancer, treated with this modern technique they maintain full their capacity sexual after receiving treatment and the biochemical control of the disease is 93% at age five by what it can be said that this technique has great advantages compared to conventional radiotherapy or with the own radical Prostate Surgery ”.

A comfortable and safe for the patient technique

Robotic CyberKnife radiotherapy allows an excellent capacity to monitor the tumor during a submillimetre precision radiation, applying only the tumor a high dose of radiation reflecting a decrease toxicity in bodies so close to the prostate as the bladder and rectum. For Dr. Silvia Sánchez, specialist in radiation oncology radiotherapy and radiosurgery robotic – Grupo IMO CyberKnife Center of is a treatment of precision where the security of the process translates into a guarantee of quality and comfort for patients diagnosed with early stage prostate cancer ”.

Placement of seeds of gold

For Dr. García, the treatment begins with the placement in the prostate of three radio-opaque markers of gold, which is performed on an outpatient basis using transrectal ultrasound and that will allow us to make radiotherapy with the CyberKnife VSI system, guided by image and its follow-up in real time ”. To the seven days of the placement of markers, takes place the patient a TAC that will be very important for the planning of the procedure and check the proper during treatment monitoring, so that this is effective. Meanwhile Dr. Silvia Sanchez assures that, with the system, CyberKnife found prostate cancer patients have an excellent response with a biochemical control at age five of 93% and with little or no toxicity, which translates into a better quality of life for the patient, compared to other conventional radiotherapy or surgery procedures. In this sense, between 80 and 90% of this type of patients treated with CyberKnife maintain a proper sexual function and more than 95% do not present important urinary tract toxicity; figures which are difficult to reach with other modalities of treatment commonly used. ”

El Dr. Rafael García y la Dra. Silvia Sanchez

fewer sessions than with conventional radiotherapy treatment

are only required five days without hospital admission, and post-surgical recovery and treatment, of a duration per session between 40 and 50 minutes so the patient can immediately resume your activity normal. during the administration of the radiotherapy treatment – says Dr. Garcia. the system takes a series of x-ray images that are automatically compared to those obtained through TAC prior to treatment, in such a way that the robot integrated in the CyberKnife system detects immediately and in real time the location of the lesion and manages the beam of radiation directly to the tumoravoiding the margin of error. With this system got the radiotherapy machine suits at all times to the patient and not the patient to the machine as it is the case with other conventional procedures .

Better quality of life for the patient

From April 2011 the IMO group is the only Center that has a team CyberKnife VSI system in our country, the most advanced technology for the treatment of different types of tumors with radiotherapy and radiosurgery.

today the clinical experience of one hundred fifty thousand patients treated at 300 computers installed worldwide and more than 500 scientific publications attest the advantages of this therapeutic procedure.